Tag: radiopharmaceuticals
Clarity and Nucleus RadioPharma scale up manufacturing for cancer treatment
Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, has entered into a Master Services Agreement (MSA) and Clinical Manufacturing Agreement for the production of 67Cu-SAR-bisPSMA, a radiopharmaceutical treatment for prostate cancer.
Telix Pharmaceuticals announces manufacturing partnership with Japan’s JFE
Melbourne-based biopharmaceutical company Telix Pharmaceuticals has announced a manufacturing partnership with JFE Engineering Corporation, a Japanese company with extensive expertise in the installation of...
Australia set to become a major supplier of nuclear medicine
Australia broke ground on a new, A$168 million nuclear medicine facility, which will manufacture radiopharmaceuticals used to diagnose cancer and heart disease.
According to the...
Featured Article
Smarter energy decisions: GridBeyond unveils AI-powered Bid Optimiser in Australia
As Australia’s energy transition accelerates, businesses participating in the National Electricity Market (NEM) are facing growing challenges in managing their energy assets efficiently.
